Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Markers for the angiogenic potential of fat grafts.

Teufelsbauer M., Stickler S., Eggerstorfer MT., Hammond DC., Lang C., Hamilton G.

Laboratory Study on Chronic Wound, published in Wien Klin Wochenschr (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Wien Klin Wochenschr (2025)
Country
Austria
Reported sample size
—
Source database
PubMed
PMID
40232500
PMCID
PMC12592318
DOI
10.1007/s00508-025-02532-8

Abstract (original English)

Background Fat grafting is widely utilized in reconstructive and esthetic plastic surgery, typically with minimal complications. Nevertheless, the occurrence of fat necrosis is dependent on the technique used for fat extraction, tissue processing and the volume of the graft. The longevity of the graft critically depends on the presence of adipose-derived stromal cells (ADSC) and their promotion of a reconstituted vascular supply. Objective This study seeks to determine whether there are differences in 13 angiogenesis-related adipokines based on their grouping by vascular endothelial growth factor (VEGF) expression levels. Methods The expression of 14 adipokines related to angiogenesis in 12 cultured ADSCs was evaluated using Human Adipokine Profiler kits, which simultaneously detect 58 mediators. Adipokines of the high and low VEGF expression groups were evaluated for their expression of the remaining 13 angiogenic proteins. Results We were able to show that there are significant differences in VEGF low and VEGF high ADSCs regarding fibroblast growth factor 19 (p = 0.043) and insulin like growth factor binding protein 3 (p = 0.028). Furthermore, ADSCs with differentially highly expressed VEGF show a different pattern in the amount of protein levels regarding the 13 other adipokines observed. Conclusion The VEGF has been described as a key angiogenic factor in fat grafts that ma

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAdipose TissueNeovascularization, PhysiologicBiomarkersAdipokinesVascular Endothelial Growth Factor ACells, CulturedFemaleMaleMiddle Aged

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research